Envestnet Asset Management Inc Tekla Life Sciences Investors Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Envestnet Asset Management Inc holds 11,058 shares of HQL stock, worth $141,874. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,058Holding current value
$141,874% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
81Shares Held
9.44MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$44 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.58 Million0.17% of portfolio
-
Karpus Management, Inc. Pittsford, NY490KShares$6.28 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.35 Million0.12% of portfolio
-
Morgan Stanley New York, NY366KShares$4.69 Million0.0% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...